About BlockMed Pro

BlockMed Pro provides a patient-centric EHR platform leveraging AI and blockchain for secure health data management. It empowers patients to control and monetize their data for research, while enabling pharmaceutical companies to access longitudinal, consented datasets for advanced analytics and drug development.

<problem> Current electronic health record (EHR) systems often lack patient control over their data and struggle with secure, transparent data sharing for research. This limits patients' ability to leverage their health information and hinders pharmaceutical companies' access to comprehensive, longitudinal data for advanced analytics and medical research. </problem> <solution> BlockMed Pro offers a patient-centric EHR platform that integrates AI and blockchain technology to provide secure, transparent, and auditable health record management. Patients gain granular control over their medical data, with the option to monetize it for research purposes through advanced pseudonymization and encryption. Pharmaceutical companies can access detailed, long-term patient data for sophisticated analytics, cohort selection, and predictive modeling. The platform's interoperability ensures seamless data flow between patients, providers, and researchers, facilitating improved treatment planning and health outcomes. </solution> <features> - Blockchain-secured EHR system ensuring data immutability and tamper-proof records. - AI-powered analytics for pattern identification, trend prediction, and data visualization from aggregated health data. - Patient-controlled data access with granular permissions and audit trails for all record interactions. - Secure data monetization framework allowing patients to consent to and be compensated for sharing their health information for research. - Advanced encryption and pseudonymization techniques to protect patient privacy while enabling data utility. - Interoperability features designed for seamless data exchange with existing healthcare systems and providers. - Machine learning models for cohort identification, outcome analysis, and treatment response tracking. </features> <target_audience> The primary target audience includes pharmaceutical companies and medical research institutions seeking high-quality, patient-consented data for drug development and clinical research, as well as healthcare providers and patients looking for a secure and empowering EHR solution. </target_audience> <revenue_model> BlockMed Pro operates on a Software as a Subscription (SaaS) model, with tiered pricing based on usage and feature access for institutional clients. </revenue_model>

What does BlockMed Pro do?

Where is BlockMed Pro located?

BlockMed Pro is based in Abu Dhabi, United Arab Emirates.

When was BlockMed Pro founded?

BlockMed Pro was founded in 2024.

How much funding has BlockMed Pro raised?

BlockMed Pro has raised 50000.

Location

Abu Dhabi, United Arab Emirates

Founded

2024

Funding

50000

Employees

3 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

BlockMed Pro

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

blockmedpro.com 100+

Crunchbase

Founded 2024 – Abu Dhabi, United Arab Emirates

Funding

Estimated Funding

Team (<5)

No team information available.

Company Description

Problem

Current electronic health record (EHR) systems often lack patient control over their data and struggle with secure, transparent data sharing for research. This limits patients' ability to leverage their health information and hinders pharmaceutical companies' access to comprehensive, longitudinal data for advanced analytics and medical research.

Solution

BlockMed Pro offers a patient-centric EHR platform that integrates AI and blockchain technology to provide secure, transparent, and auditable health record management. Patients gain granular control over their medical data, with the option to monetize it for research purposes through advanced pseudonymization and encryption. Pharmaceutical companies can access detailed, long-term patient data for sophisticated analytics, cohort selection, and predictive modeling. The platform's interoperability ensures seamless data flow between patients, providers, and researchers, facilitating improved treatment planning and health outcomes.

Features

Blockchain-secured EHR system ensuring data immutability and tamper-proof records.

AI-powered analytics for pattern identification, trend prediction, and data visualization from aggregated health data.

Patient-controlled data access with granular permissions and audit trails for all record interactions.

Secure data monetization framework allowing patients to consent to and be compensated for sharing their health information for research.

Advanced encryption and pseudonymization techniques to protect patient privacy while enabling data utility.

Interoperability features designed for seamless data exchange with existing healthcare systems and providers.

Machine learning models for cohort identification, outcome analysis, and treatment response tracking.

Target Audience

The primary target audience includes pharmaceutical companies and medical research institutions seeking high-quality, patient-consented data for drug development and clinical research, as well as healthcare providers and patients looking for a secure and empowering EHR solution.

Revenue Model

BlockMed Pro operates on a Software as a Subscription (SaaS) model, with tiered pricing based on usage and feature access for institutional clients.